Parents' views on medical decisions related to life and death for their ageing child with profound intellectual and multiple disabilities: A qualitative study.

Disabilities End-of-life decisions Medical decisions PIMD Quality of life Surrogate decision-makers

Journal

Research in developmental disabilities
ISSN: 1873-3379
Titre abrégé: Res Dev Disabil
Pays: United States
ID NLM: 8709782

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 17 09 2021
revised: 15 12 2021
accepted: 17 12 2021
pubmed: 27 12 2021
medline: 12 1 2022
entrez: 26 12 2021
Statut: ppublish

Résumé

The increased life expectancy of persons with profound intellectual and multiple disabilities (PIMD) raises questions regarding the medical decisions related to life and death, made on their behalf during their later lives. However, little is known about how parents make such decisions for their ageing child. Explore parents' views on medical decisions related to life and death for their ageing child with PIMD. We interviewed 27 parents of persons with PIMD (≥ 15 years) and analyzed the data thematically. Parents who were convinced that their ageing child's quality of life (QoL) was good, stated that their child "deserved the same treatment as any other person". Others rejected life-prolonging treatments for their child because they believed such treatment would diminish their child's QoL. Some of the parents who thought their child's QoL was poor, mentioned that withholding treatment is only an option in a crisis situation and contemplated other options to shorten their child's life. Parents feel equipped to take on a central role in medical decisions related to life and death for their ageing child with PIMD, and desire understanding from medical professionals for their views on their child's interests, which sometimes includes physician-assisted death.

Sections du résumé

BACKGROUND BACKGROUND
The increased life expectancy of persons with profound intellectual and multiple disabilities (PIMD) raises questions regarding the medical decisions related to life and death, made on their behalf during their later lives. However, little is known about how parents make such decisions for their ageing child.
AIM OBJECTIVE
Explore parents' views on medical decisions related to life and death for their ageing child with PIMD.
METHODS METHODS
We interviewed 27 parents of persons with PIMD (≥ 15 years) and analyzed the data thematically.
RESULTS RESULTS
Parents who were convinced that their ageing child's quality of life (QoL) was good, stated that their child "deserved the same treatment as any other person". Others rejected life-prolonging treatments for their child because they believed such treatment would diminish their child's QoL. Some of the parents who thought their child's QoL was poor, mentioned that withholding treatment is only an option in a crisis situation and contemplated other options to shorten their child's life.
CONCLUSIONS CONCLUSIONS
Parents feel equipped to take on a central role in medical decisions related to life and death for their ageing child with PIMD, and desire understanding from medical professionals for their views on their child's interests, which sometimes includes physician-assisted death.

Identifiants

pubmed: 34954670
pii: S0891-4222(21)00303-6
doi: 10.1016/j.ridd.2021.104154
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104154

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Auteurs

Kasper Kruithof (K)

Department of Ethics, Law & Humanities, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands. Electronic address: k.kruithof@amsterdamumc.nl.

Erik Olsman (E)

Department of Mediating Good Life, Section of Spiritual Care & Chaplaincy Studies, Protestant Theological University, Groningen, the Netherlands.

Appolonia Nieuwenhuijse (A)

Department of Ethics, Law & Humanities, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.

Dick Willems (D)

Department of Ethics, Law & Humanities, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH